| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adhesion proteins in cellular tight junctions: critical components in the modulation of paracellular permeability
|
Mrsny, Randall J.
|
|
2005
|
136-137 |
6 |
p. 809-810
2 p.
|
artikel
|
| 2 |
Advanced screening assays to rapidly identify solubility-enhancing formulations: High-throughput, miniaturization and automation
|
Dai, Wei-Guo
|
|
2008
|
136-137 |
6 |
p. 657-672
16 p.
|
artikel
|
| 3 |
Advances in lipid nanodispersions for parenteral drug delivery and targeting
|
Constantinides, Panayiotis P.
|
|
2008
|
136-137 |
6 |
p. 757-767
11 p.
|
artikel
|
| 4 |
Advances in oral drug delivery: improved bioavailability of poorly absorbed drugs by tissue and cellular optimization
|
Morishita, Mariko
|
|
2012
|
136-137 |
6 |
p. 479-
1 p.
|
artikel
|
| 5 |
Apical membrane receptors on intestinal M cells: potential targets for vaccine delivery
|
Brayden, David J.
|
|
2004
|
136-137 |
6 |
p. 721-726
6 p.
|
artikel
|
| 6 |
Applying the biopharmaceutics classification system to veterinary pharmaceutical products
|
Martinez, Marilyn
|
|
2002
|
136-137 |
6 |
p. 825-850
26 p.
|
artikel
|
| 7 |
Applying the Biopharmaceutics Classification System to veterinary pharmaceutical products
|
Martinez, Marilyn
|
|
2002
|
136-137 |
6 |
p. 805-824
20 p.
|
artikel
|
| 8 |
Approaches for the development of solid and semi-solid lipid-based formulations
|
Jannin, V.
|
|
2008
|
136-137 |
6 |
p. 734-746
13 p.
|
artikel
|
| 9 |
A strategic approach to vaccine development: animal models, monitoring vaccine efficacy, formulation and delivery
|
Griffin, J.Frank T
|
|
2002
|
136-137 |
6 |
p. 851-861
11 p.
|
artikel
|
| 10 |
Biopharmaceutical challenges associated with drugs with low aqueous solubility—The potential impact of lipid-based formulations
|
O'Driscoll, C.M.
|
|
2008
|
136-137 |
6 |
p. 617-624
8 p.
|
artikel
|
| 11 |
CAR: A virus receptor within the tight junction
|
Coyne, Carolyn B.
|
|
2005
|
136-137 |
6 |
p. 869-882
14 p.
|
artikel
|
| 12 |
Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration
|
Cole, Ewart T.
|
|
2008
|
136-137 |
6 |
p. 747-756
10 p.
|
artikel
|
| 13 |
Characterization of lipid nanoparticles by differential scanning calorimetry, X-ray and neutron scattering
|
Bunjes, Heike
|
|
2007
|
136-137 |
6 |
p. 379-402
24 p.
|
artikel
|
| 14 |
Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles
|
Wong, Ho Lun
|
|
2007
|
136-137 |
6 |
p. 491-504
14 p.
|
artikel
|
| 15 |
Controlling drug nanoparticle formation by rapid precipitation
|
D'Addio, Suzanne M.
|
|
2011
|
136-137 |
6 |
p. 417-426
10 p.
|
artikel
|
| 16 |
Corrigendum to “Carbon nanofibers and carbon nanotubes in regenerative medicine”[Advanced Drug Delivery Review 61(2009) 1097–1114]
|
Tran, Phong A.
|
|
2010
|
136-137 |
6 |
p. 667-
1 p.
|
artikel
|
| 17 |
Dendritic cells and oral transmission of prion diseases
|
Huang, Fang-Ping
|
|
2004
|
136-137 |
6 |
p. 901-913
13 p.
|
artikel
|
| 18 |
DNA and carbon nanotubes as medicine
|
Cheung, William
|
|
2010
|
136-137 |
6 |
p. 633-649
17 p.
|
artikel
|
| 19 |
DNA-based nano-sized systems for pharmaceutical and biomedical applications
|
Nishikawa, Makiya
|
|
2010
|
136-137 |
6 |
p. 626-632
7 p.
|
artikel
|
| 20 |
DNA nanomedicine: Engineering DNA as a polymer for therapeutic and diagnostic applications
|
Campolongo, Michael J.
|
|
2010
|
136-137 |
6 |
p. 606-616
11 p.
|
artikel
|
| 21 |
DNA Self-assembly for Nanomedicine
|
Chhabra, Rahul
|
|
2010
|
136-137 |
6 |
p. 617-625
9 p.
|
artikel
|
| 22 |
Drug administration to poultry
|
Vermeulen, B
|
|
2002
|
136-137 |
6 |
p. 795-803
9 p.
|
artikel
|
| 23 |
Editorial Board
|
|
|
2009
|
136-137 |
6 |
p. ii-
1 p.
|
artikel
|
| 24 |
Editorial Board
|
|
|
2013
|
136-137 |
6 |
p. ii-
1 p.
|
artikel
|
| 25 |
Editorial Board
|
|
|
2010
|
136-137 |
6 |
p. ii-
1 p.
|
artikel
|
| 26 |
Editorial Board
|
|
|
2003
|
136-137 |
6 |
p. ii-
1 p.
|
artikel
|
| 27 |
Editorial Board
|
|
|
2002
|
136-137 |
6 |
p. ii-
1 p.
|
artikel
|
| 28 |
Editorial Board
|
|
|
2004
|
136-137 |
6 |
p. ii-
1 p.
|
artikel
|
| 29 |
Editorial Board
|
|
|
2008
|
136-137 |
6 |
p. ii-
1 p.
|
artikel
|
| 30 |
Editorial Board
|
|
|
2005
|
136-137 |
6 |
p. ii-
1 p.
|
artikel
|
| 31 |
Editorial Board
|
|
|
2007
|
136-137 |
6 |
p. ii-
1 p.
|
artikel
|
| 32 |
Editorial Board
|
|
|
2012
|
136-137 |
6 |
p. ii-
1 p.
|
artikel
|
| 33 |
Editorial Board
|
|
|
2011
|
136-137 |
6 |
p. ii-
1 p.
|
artikel
|
| 34 |
Effects of nanomaterial physicochemical properties on in vivo toxicity
|
Aillon, Kristin L.
|
|
2009
|
136-137 |
6 |
p. 457-466
10 p.
|
artikel
|
| 35 |
Emerging significance of plasmid DNA nuclear import in gene therapy
|
Munkonge, Felix M.
|
|
2003
|
136-137 |
6 |
p. 749-760
12 p.
|
artikel
|
| 36 |
Engineering RNA for Targeted siRNA Delivery and Medical Application
|
Guo, Peixuan
|
|
2010
|
136-137 |
6 |
p. 650-666
17 p.
|
artikel
|
| 37 |
Enhancing drug absorption using lipids: A case study presenting the development and pharmacological evaluation of a novel lipid-based oral amphotericin B formulation for the treatment of systemic fungal infections
|
Sachs-Barrable, Kristina
|
|
2008
|
136-137 |
6 |
p. 692-701
10 p.
|
artikel
|
| 38 |
Enhancing intestinal drug solubilisation using lipid-based delivery systems
|
Porter, Christopher J.H.
|
|
2008
|
136-137 |
6 |
p. 673-691
19 p.
|
artikel
|
| 39 |
Establishment of Mycobacterium avium subsp. paratuberculosis infection in the intestine of ruminants
|
Sigurðardóttir, Ólöf G
|
|
2004
|
136-137 |
6 |
p. 819-834
16 p.
|
artikel
|
| 40 |
Formation, characterization, and fate of inhaled drug nanoparticles
|
Zhang, Jian
|
|
2011
|
136-137 |
6 |
p. 441-455
15 p.
|
artikel
|
| 41 |
Formulation of lipid-based delivery systems for oral administration: Materials, methods and strategies
|
Pouton, Colin W.
|
|
2008
|
136-137 |
6 |
p. 625-637
13 p.
|
artikel
|
| 42 |
From biology to materials: engineering DNA and RNA for drug delivery and nanomedicine
|
Luo, Dan
|
|
2010
|
136-137 |
6 |
p. 591-
1 p.
|
artikel
|
| 43 |
Guide to Authors
|
|
|
2003
|
136-137 |
6 |
p. 773-775
3 p.
|
artikel
|
| 44 |
Guide to Authors
|
|
|
2002
|
136-137 |
6 |
p. 883-885
3 p.
|
artikel
|
| 45 |
Guide to Authors
|
|
|
2004
|
136-137 |
6 |
p. 921-924
4 p.
|
artikel
|
| 46 |
Guide to Authors
|
|
|
2005
|
136-137 |
6 |
p. 929-933
5 p.
|
artikel
|
| 47 |
Gut-associated lymphoid tissues for the development of oral vaccines
|
Kunisawa, Jun
|
|
2012
|
136-137 |
6 |
p. 523-530
8 p.
|
artikel
|
| 48 |
Helminths at mucosal barriers—interaction with the immune system
|
Mulcahy, Grace
|
|
2004
|
136-137 |
6 |
p. 853-868
16 p.
|
artikel
|
| 49 |
Host intestinal epithelial response to Cryptosporidium parvum
|
Deng, Mingqi
|
|
2004
|
136-137 |
6 |
p. 869-884
16 p.
|
artikel
|
| 50 |
ICAM-1: targeted docking for exogenous as well as endogenous ligands
|
Hopkins, Ann M.
|
|
2004
|
136-137 |
6 |
p. 763-778
16 p.
|
artikel
|
| 51 |
Immunological aspects of controlled antigen delivery
|
Lofthouse, Shari
|
|
2002
|
136-137 |
6 |
p. 863-870
8 p.
|
artikel
|
| 52 |
Intestinal epithelial tight junctions as targets for enteric bacteria-derived toxins
|
Fasano, Alessio
|
|
2004
|
136-137 |
6 |
p. 795-807
13 p.
|
artikel
|
| 53 |
In vitro and in vivo models for the study of oral delivery of nanoparticles
|
Gamboa, Jennifer M.
|
|
2013
|
136-137 |
6 |
p. 800-810
11 p.
|
artikel
|
| 54 |
In vitro assessments of nanomaterial toxicity
|
Jones, Clinton F.
|
|
2009
|
136-137 |
6 |
p. 438-456
19 p.
|
artikel
|
| 55 |
Involvement of gut-associated lymphoid tissue of ruminants in the spread of transmissible spongiform encephalopathies
|
Press, Charles McL
|
|
2004
|
136-137 |
6 |
p. 885-899
15 p.
|
artikel
|
| 56 |
Lipid-based delivery systems and intestinal lymphatic drug transport: A mechanistic update
|
Trevaskis, Natalie L.
|
|
2008
|
136-137 |
6 |
p. 702-716
15 p.
|
artikel
|
| 57 |
Lipid-based systems for the enhanced delivery of poorly water soluble drugs
|
Porter, Christopher J.H.
|
|
2008
|
136-137 |
6 |
p. 615-616
2 p.
|
artikel
|
| 58 |
Lipid excipients and delivery systems for pharmaceutical development: A regulatory perspective
|
Chen, Mei-Ling
|
|
2008
|
136-137 |
6 |
p. 768-777
10 p.
|
artikel
|
| 59 |
Lipid nanoparticles for improved topical application of drugs for skin diseases
|
Schäfer-Korting, Monika
|
|
2007
|
136-137 |
6 |
p. 427-443
17 p.
|
artikel
|
| 60 |
Lipid nanoparticles: perspectives and challenges
|
Gasco, Maria Rosa
|
|
2007
|
136-137 |
6 |
p. 377-378
2 p.
|
artikel
|
| 61 |
Lipid nanoparticles: recent advances
|
Müller, Rainer H.
|
|
2007
|
136-137 |
6 |
p. 375-376
2 p.
|
artikel
|
| 62 |
Magnetic nanoparticles for theragnostics
|
Shubayev, Veronica I.
|
|
2009
|
136-137 |
6 |
p. 467-477
11 p.
|
artikel
|
| 63 |
Mechanism of intestinal entry of infectious prion protein in the pathogenesis of variant Creutzfeldt–Jakob disease
|
Ghosh, Subrata
|
|
2004
|
136-137 |
6 |
p. 915-920
6 p.
|
artikel
|
| 64 |
Mechanism of oral tolerance induction to therapeutic proteins
|
Wang, Xiaomei
|
|
2013
|
136-137 |
6 |
p. 759-773
15 p.
|
artikel
|
| 65 |
Mechanisms of nuclear transport and interventions
|
Gasiorowski, Joshua Z.
|
|
2003
|
136-137 |
6 |
p. 703-716
14 p.
|
artikel
|
| 66 |
Microbes and their products—physiological effects upon mammalian mucosa
|
Viswanathan, V.K
|
|
2004
|
136-137 |
6 |
p. 727-762
36 p.
|
artikel
|
| 67 |
Microfabrication technologies for oral drug delivery
|
Sant, Shilpa
|
|
2012
|
136-137 |
6 |
p. 496-507
12 p.
|
artikel
|
| 68 |
Modification of physicochemical characteristics of active pharmaceutical ingredients and application of supersaturatable dosage forms for improving bioavailability of poorly absorbed drugs
|
Kawakami, Kohsaku
|
|
2012
|
136-137 |
6 |
p. 480-495
16 p.
|
artikel
|
| 69 |
Molecular diagnostic and drug delivery agents based on aptamer-nanomaterial conjugates
|
Lee, Jung Heon
|
|
2010
|
136-137 |
6 |
p. 592-605
14 p.
|
artikel
|
| 70 |
Molecular mechanisms that regulate transcription factor localization suggest new targets for drug development
|
Lee, Sang-Hyun
|
|
2003
|
136-137 |
6 |
p. 717-731
15 p.
|
artikel
|
| 71 |
Molecular perspective on tight-junction assembly and epithelial polarity
|
Miyoshi, Jun
|
|
2005
|
136-137 |
6 |
p. 815-855
41 p.
|
artikel
|
| 72 |
Multi-compartmental oral delivery systems for nucleic acid therapy in the gastrointestinal tract
|
Kriegel, Christina
|
|
2013
|
136-137 |
6 |
p. 891-901
11 p.
|
artikel
|
| 73 |
Nanodrug particles and nanoformulations for drug delivery
|
Chan, Hak-Kim
|
|
2011
|
136-137 |
6 |
p. 405-
1 p.
|
artikel
|
| 74 |
Nanoparticle- and biomaterials-mediated oral delivery for drug, gene, and immunotherapy
|
Leong, Kam W.
|
|
2013
|
136-137 |
6 |
p. 757-758
2 p.
|
artikel
|
| 75 |
Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy
|
Aggarwal, Parag
|
|
2009
|
136-137 |
6 |
p. 428-437
10 p.
|
artikel
|
| 76 |
Nanoparticles and microparticles for skin drug delivery
|
Prow, Tarl W.
|
|
2011
|
136-137 |
6 |
p. 470-491
22 p.
|
artikel
|
| 77 |
Nanoparticles for oral delivery: Targeted nanoparticles with peptidic ligands for oral protein delivery
|
Yun, Yeonhee
|
|
2013
|
136-137 |
6 |
p. 822-832
11 p.
|
artikel
|
| 78 |
Nanosizing for oral and parenteral drug delivery: A perspective on formulating poorly-water soluble compounds using wet media milling technology
|
Merisko-Liversidge, Elaine
|
|
2011
|
136-137 |
6 |
p. 427-440
14 p.
|
artikel
|
| 79 |
Nanostructured lipid carriers (NLC) in cosmetic dermal products
|
Müller, R.H.
|
|
2007
|
136-137 |
6 |
p. 522-530
9 p.
|
artikel
|
| 80 |
Nanotoxicity assessment: all small talk?
|
Grainger, David W.
|
|
2009
|
136-137 |
6 |
p. 419-421
3 p.
|
artikel
|
| 81 |
Nuclear transport: an emerging opportunity for drug targeting
|
|
|
2003
|
136-137 |
6 |
p. 699-702
4 p.
|
artikel
|
| 82 |
Occludin: Structure, function and regulation
|
Feldman, Gemma J.
|
|
2005
|
136-137 |
6 |
p. 883-917
35 p.
|
artikel
|
| 83 |
Oral biodrug delivery using cell-penetrating peptide
|
Khafagy, El-Sayed
|
|
2012
|
136-137 |
6 |
p. 531-539
9 p.
|
artikel
|
| 84 |
Oral colon delivery of insulin with the aid of functional adjuvants
|
Maroni, Alessandra
|
|
2012
|
136-137 |
6 |
p. 540-556
17 p.
|
artikel
|
| 85 |
Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells
|
Kwon, Kwang-Chul
|
|
2013
|
136-137 |
6 |
p. 782-799
18 p.
|
artikel
|
| 86 |
Oral delivery of proteins by biodegradable nanoparticles
|
Bakhru, Sasha H.
|
|
2013
|
136-137 |
6 |
p. 811-821
11 p.
|
artikel
|
| 87 |
Oral drug delivery systems using chemical conjugates or physical complexes
|
Al-Hilal, Taslim A.
|
|
2013
|
136-137 |
6 |
p. 845-864
20 p.
|
artikel
|
| 88 |
Oral drug delivery utilizing intestinal OATP transporters
|
Tamai, Ikumi
|
|
2012
|
136-137 |
6 |
p. 508-514
7 p.
|
artikel
|
| 89 |
Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers
|
Ensign, Laura M.
|
|
2012
|
136-137 |
6 |
p. 557-570
14 p.
|
artikel
|
| 90 |
Oral immunotherapy for food allergy: Clinical and preclinical studies
|
Kulis, Mike
|
|
2013
|
136-137 |
6 |
p. 774-781
8 p.
|
artikel
|
| 91 |
Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles
|
Date, Abhijit A.
|
|
2007
|
136-137 |
6 |
p. 505-521
17 p.
|
artikel
|
| 92 |
Pathogen invasion across intestine: mechanisms and potential exploitation
|
Brayden, David J
|
|
2004
|
136-137 |
6 |
p. 717-719
3 p.
|
artikel
|
| 93 |
Pharmaceutical challenges in veterinary product development
|
Ahmed, Imran
|
|
2002
|
136-137 |
6 |
p. 871-882
12 p.
|
artikel
|
| 94 |
Pharmaceutical nanotechnology for oral delivery of anticancer drugs
|
Mei, Lin
|
|
2013
|
136-137 |
6 |
p. 880-890
11 p.
|
artikel
|
| 95 |
Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug
|
Hanafy, A.
|
|
2007
|
136-137 |
6 |
p. 419-426
8 p.
|
artikel
|
| 96 |
Physical and chemical stability of drug nanoparticles
|
Wu, Libo
|
|
2011
|
136-137 |
6 |
p. 456-469
14 p.
|
artikel
|
| 97 |
Poliovirus vaccine strains as mucosal vaccine vectors and their potential use to develop an AIDS vaccine
|
Crotty, Shane
|
|
2004
|
136-137 |
6 |
p. 835-852
18 p.
|
artikel
|
| 98 |
Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption
|
Custodio, Joseph M.
|
|
2008
|
136-137 |
6 |
p. 717-733
17 p.
|
artikel
|
| 99 |
Probiotics in inflammatory bowel disease—therapeutic rationale and role
|
Shanahan, Fergus
|
|
2004
|
136-137 |
6 |
p. 809-818
10 p.
|
artikel
|
| 100 |
Production methods for nanodrug particles using the bottom-up approach
|
Chan, Hak-Kim
|
|
2011
|
136-137 |
6 |
p. 406-416
11 p.
|
artikel
|
| 101 |
Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system
|
Chattopadhyay, P.
|
|
2007
|
136-137 |
6 |
p. 444-453
10 p.
|
artikel
|
| 102 |
Rafts and related glycosphingolipid-enriched microdomains in the intestinal epithelium: bacterial targets linked to nutrient absorption
|
Taı̈eb, Nadira
|
|
2004
|
136-137 |
6 |
p. 779-794
16 p.
|
artikel
|
| 103 |
Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules
|
Chen, Mei-Chin
|
|
2013
|
136-137 |
6 |
p. 865-879
15 p.
|
artikel
|
| 104 |
Regulatory perspective on the importance of ADME assessment of nanoscale material containing drugs
|
Zolnik, Banu S.
|
|
2009
|
136-137 |
6 |
p. 422-427
6 p.
|
artikel
|
| 105 |
Role of claudins in tumorigenesis
|
Swisshelm, Karen
|
|
2005
|
136-137 |
6 |
p. 919-928
10 p.
|
artikel
|
| 106 |
Role of the cytoskeleton in nuclear import
|
Campbell, Edward M.
|
|
2003
|
136-137 |
6 |
p. 761-771
11 p.
|
artikel
|
| 107 |
Solid lipid nanoparticles as a drug delivery system for peptides and proteins
|
Almeida, António J.
|
|
2007
|
136-137 |
6 |
p. 478-490
13 p.
|
artikel
|
| 108 |
Solid lipid nanoparticles for targeted brain drug delivery
|
Blasi, Paolo
|
|
2007
|
136-137 |
6 |
p. 454-477
24 p.
|
artikel
|
| 109 |
Spiral progression in the development of absorption enhancers based on the biology of tight junctions
|
Kondoh, Masuo
|
|
2012
|
136-137 |
6 |
p. 515-522
8 p.
|
artikel
|
| 110 |
Stability of lipid excipients in solid lipid nanoparticles
|
Radomska-Soukharev, Anna
|
|
2007
|
136-137 |
6 |
p. 411-418
8 p.
|
artikel
|
| 111 |
Structure and dynamics of drug-carrier systems as studied by parelectric spectroscopy
|
Blaschke, T.
|
|
2007
|
136-137 |
6 |
p. 403-410
8 p.
|
artikel
|
| 112 |
Targeted nanoparticles with novel non-peptidic ligands for oral delivery
|
des Rieux, Anne
|
|
2013
|
136-137 |
6 |
p. 833-844
12 p.
|
artikel
|
| 113 |
The JAM family of proteins
|
Mandell, Kenneth J.
|
|
2005
|
136-137 |
6 |
p. 857-867
11 p.
|
artikel
|
| 114 |
Tight junctions, from tight intercellular seals to sophisticated protein complexes involved in drug delivery, pathogens interaction and cell proliferation
|
Gonzalez-Mariscal, Lorenza
|
|
2005
|
136-137 |
6 |
p. 811-814
4 p.
|
artikel
|
| 115 |
Transepithelial transport and toxicity of PAMAM dendrimers: Implications for oral drug delivery
|
Sadekar, S.
|
|
2012
|
136-137 |
6 |
p. 571-588
18 p.
|
artikel
|
| 116 |
Veterinary drug delivery (Part V)
|
|
|
2002
|
136-137 |
6 |
p. 785-
1 p.
|
artikel
|
| 117 |
Virus nuclear import
|
Whittaker, Gary R.
|
|
2003
|
136-137 |
6 |
p. 733-747
15 p.
|
artikel
|
| 118 |
What determines drug solubility in lipid vehicles: Is it predictable?
|
Rane, Sagar S.
|
|
2008
|
136-137 |
6 |
p. 638-656
19 p.
|
artikel
|
| 119 |
Zebrafish as a correlative and predictive model for assessing biomaterial nanotoxicity
|
Fako, Valerie E.
|
|
2009
|
136-137 |
6 |
p. 478-486
9 p.
|
artikel
|
| 120 |
Zoological pharmacology: current status, issues, and potential
|
Hunter, Robert P
|
|
2002
|
136-137 |
6 |
p. 787-793
7 p.
|
artikel
|
Tijdschrift beschrijving